Skip to main content
Erschienen in: Infection 4/2016

30.01.2016 | Case Report

The rationale for third trimester testing of vertical HIV transmission in neonates with CMV infection

verfasst von: Vinzenz Boos, Cornelia Feiterna-Sperling, Akosua Sarpong, Lars Garten, Malte Cremer, Katharina von Weizsäcker, Christoph Bührer, Christof Dame

Erschienen in: Infection | Ausgabe 4/2016

Einloggen, um Zugang zu erhalten

Abstract

We report on a late-preterm neonate with severe congenital cytomegalovirus (CMV) infection, refractory to antiviral therapy with ganciclovir. Subsequent immune diagnostics led to the finding of HIV infection at day 69, even though the mother tested negative for HIV in early pregnancy. Thus, in congenital CMV infection, HIV testing should be performed to elucidate maternal HIV seroconversion during late pregnancy. Our case strongly supports third trimester screening of HIV infection acquired during pregnancy, yet recommended only for women with traditional risk factors for HIV or living in an area of high HIV prevalence.
Literatur
1.
Zurück zum Zitat Kenneson A, Cannon MJ. Review and meta-analysis of the epidemiology of congenital cytomegalovirus (CMV) infection. Rev Med Virol. 2007;17:253–76.CrossRefPubMed Kenneson A, Cannon MJ. Review and meta-analysis of the epidemiology of congenital cytomegalovirus (CMV) infection. Rev Med Virol. 2007;17:253–76.CrossRefPubMed
2.
Zurück zum Zitat Oliver SE, Cloud GA, Sánchez PJ, et al. Neurodevelopmental outcomes following ganciclovir therapy in symptomatic congenital cytomegalovirus infections involving the central nervous system. J Clin Virol. 2009;46:22–6.CrossRef Oliver SE, Cloud GA, Sánchez PJ, et al. Neurodevelopmental outcomes following ganciclovir therapy in symptomatic congenital cytomegalovirus infections involving the central nervous system. J Clin Virol. 2009;46:22–6.CrossRef
3.
Zurück zum Zitat Kimberlin DW, Acosta EP, Sánchez PJ, et al. Pharmacokinetic and pharmacodynamic assessment of oral valganciclovir in the treatment of symptomatic congenital cytomegalovirus disease. J Infect Dis. 2008;197:836–45.CrossRefPubMed Kimberlin DW, Acosta EP, Sánchez PJ, et al. Pharmacokinetic and pharmacodynamic assessment of oral valganciclovir in the treatment of symptomatic congenital cytomegalovirus disease. J Infect Dis. 2008;197:836–45.CrossRefPubMed
4.
Zurück zum Zitat Cremer M, Weimann A, Schmalisch G, et al. Immature platelet values indicate impaired megakaryopoietic activity in neonatal early-onset thrombocytopenia. Thromb Haemost. 2010;103:1016–21.CrossRefPubMed Cremer M, Weimann A, Schmalisch G, et al. Immature platelet values indicate impaired megakaryopoietic activity in neonatal early-onset thrombocytopenia. Thromb Haemost. 2010;103:1016–21.CrossRefPubMed
5.
Zurück zum Zitat Roux W, Pieper C, Connon M. Thrombocytopenia as marker for HIV exposure in the neonate. J Trop Pediatr. 2001;47:208–10.CrossRefPubMed Roux W, Pieper C, Connon M. Thrombocytopenia as marker for HIV exposure in the neonate. J Trop Pediatr. 2001;47:208–10.CrossRefPubMed
6.
Zurück zum Zitat Duryea EL, Sánchez PJ, Sheffield JS, et al. Maternal human immunodeficiency virus infection and congenital transmission of cytomegalovirus. Pediatr Infect Dis J. 2010;29:915–8.CrossRefPubMed Duryea EL, Sánchez PJ, Sheffield JS, et al. Maternal human immunodeficiency virus infection and congenital transmission of cytomegalovirus. Pediatr Infect Dis J. 2010;29:915–8.CrossRefPubMed
7.
Zurück zum Zitat Mwaanza N, Chilukutu L, Tembo J, et al. High rates of congenital cytomegalovirus infection linked with maternal HIV infection among neonatal admissions at a large referral center in sub-Saharan Africa. Clin Infect Dis. 2014;58:728–35.CrossRefPubMed Mwaanza N, Chilukutu L, Tembo J, et al. High rates of congenital cytomegalovirus infection linked with maternal HIV infection among neonatal admissions at a large referral center in sub-Saharan Africa. Clin Infect Dis. 2014;58:728–35.CrossRefPubMed
8.
Zurück zum Zitat Frederick T, Homans J, Spencer L, et al. The effect of prenatal highly active antiretroviral therapy on the transmission of congenital and perinatal/early postnatal cytomegalovirus among HIV-infected and HIV-exposed infants. Clin Infect Dis. 2012;55:877–84.CrossRefPubMed Frederick T, Homans J, Spencer L, et al. The effect of prenatal highly active antiretroviral therapy on the transmission of congenital and perinatal/early postnatal cytomegalovirus among HIV-infected and HIV-exposed infants. Clin Infect Dis. 2012;55:877–84.CrossRefPubMed
9.
Zurück zum Zitat Moses SE, Tosswill J, Sudhanva M, et al. HIV-1 seroconversion during pregnancy resulting in vertical transmission. J Clin Virol. 2008;41:152–3.CrossRefPubMed Moses SE, Tosswill J, Sudhanva M, et al. HIV-1 seroconversion during pregnancy resulting in vertical transmission. J Clin Virol. 2008;41:152–3.CrossRefPubMed
10.
Zurück zum Zitat Roongpisuthipong A, Siriwasin W, Simonds RJ, et al. HIV seroconversion during pregnancy and risk for mother-to-infant transmission. J Acquir Immune Defic Syndr. 2001;26:348–51.CrossRefPubMed Roongpisuthipong A, Siriwasin W, Simonds RJ, et al. HIV seroconversion during pregnancy and risk for mother-to-infant transmission. J Acquir Immune Defic Syndr. 2001;26:348–51.CrossRefPubMed
11.
Zurück zum Zitat Johnson LF, Stinson K, Newell ML, et al. The contribution of maternal HIV seroconversion during late pregnancy and breastfeeding to mother-to-child transmission of HIV. J Acquir Immune Defic Syndr. 2012;59:417–25.CrossRefPubMedPubMedCentral Johnson LF, Stinson K, Newell ML, et al. The contribution of maternal HIV seroconversion during late pregnancy and breastfeeding to mother-to-child transmission of HIV. J Acquir Immune Defic Syndr. 2012;59:417–25.CrossRefPubMedPubMedCentral
12.
Zurück zum Zitat De Schacht C, Hoffmann HJ, Mabunda N, et al. High rates of HIV seroconversion in pregnant women and low reported levels of HIV testing among male partners in Southern Mozambique: results from a mixed methods study. PLoS One. 2014;9:e115014.CrossRefPubMedPubMedCentral De Schacht C, Hoffmann HJ, Mabunda N, et al. High rates of HIV seroconversion in pregnant women and low reported levels of HIV testing among male partners in Southern Mozambique: results from a mixed methods study. PLoS One. 2014;9:e115014.CrossRefPubMedPubMedCentral
13.
Zurück zum Zitat Faghih S, Secord E. Increased adolescent HIV infection during pregnancy leads to increase in perinatal transmission at urban referral center. J Int Assoc Physicians AIDS Care (Chic). 2012;11:293–5.CrossRef Faghih S, Secord E. Increased adolescent HIV infection during pregnancy leads to increase in perinatal transmission at urban referral center. J Int Assoc Physicians AIDS Care (Chic). 2012;11:293–5.CrossRef
15.
Zurück zum Zitat Branson BM, Handsfield HH, Lampe MA, et al. Revised recommendations for HIV testing of adults, adolescents, and pregnant women in health-care settings. MMWR Recomm Rep. 2006;55(RR14):1–17.PubMed Branson BM, Handsfield HH, Lampe MA, et al. Revised recommendations for HIV testing of adults, adolescents, and pregnant women in health-care settings. MMWR Recomm Rep. 2006;55(RR14):1–17.PubMed
16.
Zurück zum Zitat Committee on Obstetric Practice and HIV Expert Work Group. Committee opinion no: 635: prenatal and perinatal human immunodeficiency virus testing: expanded recommendations. Obstet Gynecol. 2015;125:1544–7. Committee on Obstetric Practice and HIV Expert Work Group. Committee opinion no: 635: prenatal and perinatal human immunodeficiency virus testing: expanded recommendations. Obstet Gynecol. 2015;125:1544–7.
Metadaten
Titel
The rationale for third trimester testing of vertical HIV transmission in neonates with CMV infection
verfasst von
Vinzenz Boos
Cornelia Feiterna-Sperling
Akosua Sarpong
Lars Garten
Malte Cremer
Katharina von Weizsäcker
Christoph Bührer
Christof Dame
Publikationsdatum
30.01.2016
Verlag
Springer Berlin Heidelberg
Erschienen in
Infection / Ausgabe 4/2016
Print ISSN: 0300-8126
Elektronische ISSN: 1439-0973
DOI
https://doi.org/10.1007/s15010-016-0876-0

Weitere Artikel der Ausgabe 4/2016

Infection 4/2016 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Triglyzeridsenker schützt nicht nur Hochrisikopatienten

10.05.2024 Hypercholesterinämie Nachrichten

Patienten mit Arteriosklerose-bedingten kardiovaskulären Erkrankungen, die trotz Statineinnahme zu hohe Triglyzeridspiegel haben, profitieren von einer Behandlung mit Icosapent-Ethyl, und zwar unabhängig vom individuellen Risikoprofil.

Gibt es eine Wende bei den bioresorbierbaren Gefäßstützen?

In den USA ist erstmals eine bioresorbierbare Gefäßstütze – auch Scaffold genannt – zur Rekanalisation infrapoplitealer Arterien bei schwerer PAVK zugelassen worden. Das markiert einen Wendepunkt in der Geschichte dieser speziellen Gefäßstützen.

Vorsicht, erhöhte Blutungsgefahr nach PCI!

10.05.2024 Koronare Herzerkrankung Nachrichten

Nach PCI besteht ein erhöhtes Blutungsrisiko, wenn die Behandelten eine verminderte linksventrikuläre Ejektionsfraktion aufweisen. Das Risiko ist umso höher, je stärker die Pumpfunktion eingeschränkt ist.

Wie managen Sie die schmerzhafte diabetische Polyneuropathie?

10.05.2024 DDG-Jahrestagung 2024 Kongressbericht

Mit Capsaicin-Pflastern steht eine neue innovative Therapie bei schmerzhafter diabetischer Polyneuropathie zur Verfügung. Bei therapierefraktären Schmerzen stellt die Hochfrequenz-Rückenmarkstimulation eine adäquate Option dar.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.